View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Carmat: 1 director

A director at Carmat sold 103,844 shares at 0.182EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing ...

Felix Fischer ... (+7)
  • Felix Fischer
  • Filipe Botelho
  • Haidje Rustau
  • Jayanth Kandalam
  • Peter Low
  • Si Yong Ng
  • Trung Nguyen

Lucror Analytics - Morning Views Europe

In today's Morning Views publication we comment on developments of the following high yield issuers: SPIE, PeopleCert, AMS Osram, Azelis, Zegona, United Group, Banijay, Vedanta Resources, Nemak, Victoria, Itelyum Group, Seche Environnement, Ineos Quattro, Air France-KLM

 PRESS RELEASE

Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel ...

Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 8, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the half-year report of the liquidity contract with Crédit Industriel et Commercial. Under the liquidity contract GENFIT has with Crédit Industriel et Commercial, the following resources appeared on the liquidity account as of June 30, 2025: ...

 PRESS RELEASE

Genfit : Bilan semestriel du contrat de liquidité contracté avec le Cr...

Genfit : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 8 juillet 2025 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le pronostic vital, annonce aujourd’hui le bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial. Au titre du contrat de liquidité confié par la société GENFIT au Crédit Industriel et Commercial, à la ...

Adrien Frachette ... (+2)
  • Adrien Frachette
  • Christophe-Raphaël Ganet

ODDO : Profiter du momentum des SMID, repondérer les défensives

La surperformance des Small&Midcaps au S1 reste marquée par un contexte de i/ momentum sans dynamique haussière (sauf peut-être en Italie ou en Espagne), alors que les devises impacteront T2&T3, ii/ géopolitique instable, iii/ fébrilité : les 2 plus grandes puissances économiques (Chine et USA) sont en phase de pivot et/ou présentent certaines fragilités, iv/ valorisations toujours attractives (décote de 30% par rapport aux large caps, et multiples sous leurs niveaux historiques). Nous sommes ra...

Adrien Frachette ... (+2)
  • Adrien Frachette
  • Christophe-Raphaël Ganet

ODDO : Seizing SMID momentum, reweighting defensive profiles

The outperformance of small and mid caps in H1 was marked by i/ the absence of upward revision momentum (except perhaps in Italy and Spain), while forex effects are set to dent Q2 and Q3, ii/ geopolitical turmoil, iii/ a jittery market: the two biggest economic powers (China and the US) are in a period of transition and/or showing signs of weakness, iv/ attractive valuations (30% discount to large caps and multiples below historical levels). We are reasonably optimistic about small and mid caps ...

Martial Descoutures ... (+2)
  • Martial Descoutures
  • Oussema Denguir
Martial Descoutures ... (+2)
  • Martial Descoutures
  • Oussema Denguir
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch